Q2 2021 Holdings
Filed 2021-08-16 | 67 holdings | $171.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $68.7M | 521,923 | 39.9% |
| Biogen Inc(BIIB) | COMM | 09062X103 | $38.3M | 110,600 | 22.3% |
| Align Technology Inc(ALGN) | COMM | 016255101 | $28.8M | 47,093 | 16.7% |
| Agios Pharmaceuticals, Inc.(AGIO) | COMM | 00847X104 | $12.1M | 219,033 | 7.0% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $9.5M | 481,323 | 5.5% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $6.0M | 434,555 | 3.5% |
| Celldex Therapeutics, Inc.(CLDX) | COMM | 15117B202 | $4.5M | 134,724 | 2.6% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $2.5M | 158,609 | 1.5% |
| Natera(NTRA) | COMM | 632307104 | $352.0K | 3,100,560 | 0.2% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $222.6K | 1,952,441 | 0.1% |
| Aerovate Therapeutics, Inc. | COMM | 008064107 | $85.8K | 3,758,686 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $74.2K | 2,194,278 | 0.0% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $57.5K | 959,632 | 0.0% |
| iShares TRPut | iShares Biotech | 464287956 | $53.2K | 325,000 | 0.0% |
| Bolt Biotherapeutics, Inc.(BOLT1EUR) | COMM | 097702104 | $42.6K | 2,754,437 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $38.8K | 216,085 | 0.0% |
| Vera Therapeutics, Inc.(VERA) | CL A | 92337R101 | $38.7K | 2,914,776 | 0.0% |
| Inozyme Pharma, Inc. | COMM | 45790W108 | $34.6K | 2,028,308 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $30.3K | 3,083,712 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $29.3K | 233,638 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $24.6K | 581,940 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $24.0K | 844,169 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | COMM | 803607100 | $23.2K | 298,500 | 0.0% |
| ARK ETF TRPut | Genomic Rev ETF | 00214Q952 | $23.1K | 250,000 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $22.8K | 1,467,675 | 0.0% |
| Checkmate Pharmaceuticals Inc | COMM | 162818108 | $21.5K | 3,606,707 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $21.5K | 2,671,856 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COMM | 74366E102 | $20.2K | 449,082 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COMM | 64125C109 | $19.8K | 203,200 | 0.0% |
| Exelixis Inc(EXEL) | COMM | 30161Q104 | $19.7K | 1,079,681 | 0.0% |
| Akouos, Inc | COMM | 00973J101 | $19.0K | 1,515,074 | 0.0% |
| Insulet Corp(PODD) | COMM | 45784P101 | $18.8K | 68,500 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMM | 92532F100 | $17.8K | 88,214 | 0.0% |
| Regenxbio Inc(RGNX) | COMM | 75901B107 | $16.6K | 427,740 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $15.5K | 5,599,999 | 0.0% |
| Agenus Inc(AGENEUR) | COMM | 00847G705 | $15.2K | 2,769,900 | 0.0% |
| Dexcom Inc(DXCM) | COMM | 252131107 | $14.4K | 33,713 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $14.4K | 4,749,623 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COMM | 46116X101 | $12.8K | 313,159 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COMM | 60468T105 | $12.7K | 78,538 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $11.3K | 79,601 | 0.0% |
| Uniqure NV(QURE) | COMM | N90064101 | $10.0K | 324,303 | 0.0% |
| Amgen Inc(AMGN) | COMM | 031162100 | $9.9K | 40,500 | 0.0% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $9.3K | 444,372 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $6.6K | 2,400,000 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $6.3K | 234,504 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COMM | 16383L106 | $6.2K | 465,637 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COMM | 56854Q200 | $6.2K | 346,160 | 0.0% |
| Cyteir Therapeutics, Inc. | COMM | 23284P103 | $5.7K | 265,000 | 0.0% |
| FibroGen, Inc.Put | COMM | 31572Q958 | $5.3K | 200,000 | 0.0% |